Validation of the INNO-LIA syphilis kit as a confirmatory assay for Treponema pallidum antibodies.

Institute Alfred Fournier, 75014 Paris, France.
Journal of Clinical Microbiology (Impact Factor: 4.23). 01/2000; 38(1):215-9.
Source: PubMed

ABSTRACT The commercially available diagnostic tests for syphilis are mostly based on the use of extracted antigens of Treponema pallidum. Pronounced cross-reactivities with other spirochete antigens are often reported. The aim of this study was to validate a novel multiparametric assay (the assay performed with the kit) INNO-LIA Syphilis for the confirmation of syphilis antibodies in a set of 840 documented human serum samples. All serum samples were previously tested at the French World Health Organization reference center for venereal diseases (Institute Alfred Fournier, Paris, France), with a consensus result provided for each sample. The study was conducted in two phases, with each phase involving a validation set (500 well-documented serum samples) and an exploratory set (340 serum samples) of serum samples, respectively. By measuring the sensitivity and specificity, we compared the result of the new assay with the consensus result on the basis of the results of a variable number of classical serological methods and clinical information when available. A sensitivity of 99.6% (95% confidence internal [CI], 98.5 to 99.9%) and a specificity of 99.5% (95% CI, 98.1 to 99.9%) were found for the new line immunoassay. Six of seven samples with indeterminate results by classical serology tested positive with the INNO-LIA Syphilis kit. This single multiparametric assay provides reliable confirmatory diagnostic information that must currently be obtained by the performance and interpretation of results of a combination of serological assays.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background The present study was carried over a period of 2 years, from January, 2009 to December, 2010.Material and methodsThree hundred and seventy (370) drug users attending an Integrated Counselling & Testing Centre (ICTC) at Agra were screened for HIV-1/2, HBV, HCV and syphilis infections.The socio-demographic features and addiction profile of the drug users were studied.ResultsSeroprevalence of HIV infection is 4.86% (18/370), HBV was found to be 0.81% (3/370), HCV is 5.67% (21/370) and VDRL is 25.94% (96/370) among the drug users. Of these, 2 (0.54%) each were co-infected with HIV–HBV, HBV–HCV and HCV–Syphilis whereas 15 (4.05%) were co-infected with HIV–HCV and 25 (6.75%) with HIV–VDRL infections. HIV-1/2 co-infection was found in only 2 (0.54%) of the drug users. The diagnosis of co-infections was confirmed based on laboratory testing and correlated clinically, at the time of testing. The drugs most commonly used were a combination of Lupigesic, Avil and Diazepam.Conclusion The easy availability of drugs, curiosity and peer approval were the common reasons for initiation of drug abuse among those tested at this Centre. This is the first report of the HIV, HBV, HCV and VDRL screening among drug users in Agra in this region of the country.
    HIV & AIDS Review. 06/2012; 11(2):49–53.
  • [Show abstract] [Hide abstract]
    ABSTRACT: SUMMARY The agents of human treponematoses include four closely related members of the genus Treponema: three subspecies of Treponema pallidum plus Treponema carateum. T. pallidum subsp. pallidum causes venereal syphilis, while T. pallidum subsp. pertenue, T. pallidum subsp. endemicum, and T. carateum are the agents of the endemic treponematoses yaws, bejel (or endemic syphilis), and pinta, respectively. All human treponematoses share remarkable similarities in pathogenesis and clinical manifestations, consistent with the high genetic and antigenic relatedness of their etiological agents. Distinctive features have been identified in terms of age of acquisition, most common mode of transmission, and capacity for invasion of the central nervous system and fetus, although the accuracy of these purported differences is debated among investigators and no biological basis for these differences has been identified to date. In 2012, the World Health Organization (WHO) officially set a goal for yaws eradication by 2020. This challenging but potentially feasible endeavor is favored by the adoption of oral azithromycin for mass treatment and the currently focused distribution of yaws and endemic treponematoses and has revived global interest in these fascinating diseases and their causative agents.
    Clinical microbiology reviews 01/2014; 27(1):89-115. · 16.00 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Diagnosis of sexually transmitted infection (STI) currently rely upon direct characterization of pathogens agents on the site of infection. This diagnosis is far from easy. Some pathogen agents cannot be cultured upon current methods (i.e., intracellular pathogens as Chlamydia), and others cannot grow in culture media in vitro (i.e., treponema, hepatitis virus, papillomavirus). Therefore, antibodies detection against STI agents can represent a simple, reliable way for STI diagnosis since sample collection transport and automated techniques are now available. Some serological diagnosis of STI infections are commonly standardized (HIV, HBV) but caution is required when interpreting others (syphilis, Chlamydia, HSV, etc.). Facing the re-emerging of STI infection phenomenum, reliable diagnosis and interpretation clues are needed.
    Immuno-analyse & Biologie Spécialisée 02/2004; 19(1):54-65. · 0.11 Impact Factor

Full-text (2 Sources)

Available from
May 31, 2014